News and Announcements
Venture Investing in a Recession
- Published November 03, 2022 7:44AM UTC
- Publisher Maan Perez
- Categories Venture Investor Interviews
Public markets are correcting, VC money is drying up and investors are as prudent as ever. Surrounded by these signs of a depressed market, investors in the process of deploying capital may need to change their methods of analysis and deal structure in order to ensure proper entry prices.
Watch this panel session as seasoned investors discuss the best course of action for raising capital in a recession.
Panelists:
Jeb J. A. – Founder at Clearglass Capital Partners
Jenny Morel – Founder & Managing Director at Morgo
Rod Bristow – CEO at Investible
Karen Chan – Portfolio Manager at Perennial Partners
Looking for new investment opportunities? Click here to browse hundreds of companies, connect with their CEO and create your personalised deal flow.
Your AI Driven matchmaking platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Venture Investor Interviews
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
From Mediocre Portfolios to 18% Returns: EFM’s Radical Transparency in Private Markets
Tired of mediocre returns? Emerging Funds Management (EFM) Founding Partner Surendra Pather explains how his firm fills the bank funding gap for developers while delivering 18% returns to sophisticated investors through a radical, transparent fiduciary model.
Silent Pain and Smart Monitors: The High-Stakes Race to De-Risk the Operating Theatre
Anesthesia has long been considered more “art” than science, leaving clinicians to manage high-stakes sedation with aging tools. Cortical Dynamics is changing the clinical reality with BARM 2.0—an AI-powered monitor that provides real-time visibility into the brain’s response to pain and sedation, backed by a global licence and cooperation agreement with Philips and a decade of R&D.
Backed By Leading Investment Groups and Family Offices
